Origincell

Origincell is a Shanghai-based private life sciences group focused on cell storage, cell preparation, cryogenic biobanking automation, and selected cell therapy development. The company operates a broader "cell ecosphere" that includes third-party cell and biospecimen storage, automated ultra-low-temperature sample storage equipment, GMP-oriented cell preparation capabilities, and life-science industrial park infrastructure. Through subsidiaries such as Yuantian Biotech, it develops stem cell and immune cell preparation technologies and has advanced at least one mesenchymal stem cell product, YT001 injection, into the IND stage in China for knee osteoarthritis. Origincell also reports activity in tumor immunotherapy drugs and supports translational research through standardized cell products and research services. Overall, it appears to be a diversified cell-technology platform company rather than a pure-play single-asset therapeutics developer.